Increased expression of NLRP12 in prostate cancer suggest that NLRP12 may play an important role in activating NF-κB and IL-1β signaling, and its association with the pathogenesis and progression of prostate cancer. This evidence concerns the gene NFKB1 and prostate carcinoma.